Gameto

Gameto is a biotechnology company founded in 2020, dedicated to advancing women’s reproductive health.

Based in New York and Austin, Gameto focuses on addressing unmet needs for women and families throughout their reproductive years. The company employs cell engineering and in vitro biology to develop therapeutics aimed at improving fertility care. One of Gameto's key programs is Fertilo, designed for IVF and egg freezing, which seeks to make the treatment process shorter, safer, and less reliant on hormonal injections. The company also has a broader pipeline that includes Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic targeting health issues related to primary ovarian insufficiency and menopause. Gameto is committed to redefining women’s health and fertility care through innovative therapeutics.